Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings - Wikidata - awgldk - TriplyDB

Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings

Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings

http://www.wikidata.org/entity/Q34254924

about

The limits of oral therapy in pulmonary arterial hypertension management Drug treatment of pulmonary hypertension in children Pulmonary arterial hypertension: a comparison between children and adults Recent progress in understanding pediatric pulmonary hypertension Persistent Challenges in Pediatric Pulmonary Hypertension.Initial experience with tadalafil in pediatric pulmonary arterial hypertension.Pediatric pulmonary arterial hypertension.Change in Pediatric Functional Classification During Treatment and Morbidity and Mortality in Children with Pulmonary Hypertension Progress in the diagnosis and management of pulmonary hypertension in children.Evaluation of circulating proteins and hemodynamics towards predicting mortality in children with pulmonary arterial hypertension Pulmonary artery smooth muscle cell endothelin-1 expression modulates the pulmonary vascular response to chronic hypoxia Advances in pediatric pulmonary arterial hypertension.Epidemiology and clinical management of pulmonary hypertension in children.Prognostic factors in pulmonary hypertension Acute pulmonary vasodilator testing with inhaled treprostinil in children with pulmonary arterial hypertension.Stability of an Extemporaneously Compounded Oral Suspension of Bosentan.Magnetic resonance imaging of the right ventricle in pediatric pulmonary arterial hypertension Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease.Ventilatory efficiency slope correlates with functional capacity, outcomes, and disease severity in pediatric patients with pulmonary hypertension.Current challenges in pediatric pulmonary hypertension.Right ventricular to left ventricular diameter ratio at end-systole in evaluating outcomes in children with pulmonary hypertension.Pediatric pulmonary arterial hypertension: current and emerging therapeutic options.Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension.Pulmonary hypertension and breathlessness: is it a combination we can ignore?Current and advancing treatments for pulmonary arterial hypertension in childhood.Advances in paediatric pulmonary vascular disease associated with bronchopulmonary dysplasia.Treatment of pulmonary arterial hypertension in children.Treating pulmonary hypertension in pediatrics.Current Concepts in Management of Pulmonary Hypertension: Fighting the Old Demon with Modern Weapons.Sildenafil in Infants and Children Home Exercise Training in Children and Adolescents with Pulmonary Arterial Hypertension: A Pilot Study.Pediatric Development of Bosentan Facilitated by Modeling and Simulation.Pulmonary thromboendarterectomy after treatment with treprostenil in a chronic thromboembolic pulmonary hypertension patient: a case report.Clinical and prognostic value of endothelin-1 and big endothelin-1 expression in children with pulmonary hypertension.[Interstitial processes of the lungs in childhood].Sildenafil add-on therapy in paediatric pulmonary arterial hypertension, experiences of a national referral centre.Multicenter mortality and morbidity associated with pulmonary hypertension in the pediatric intensive care unit.Treatment of children with pulmonary hypertension. Expert consensus statement on the diagnosis and treatment of paediatric pulmonary hypertension. The European Paediatric Pulmonary Vascular Disease Network, endorsed by ISHLT and DGPK.Pulmonary hypertension in bronchopulmonary dysplasia

P2860

Q26773209-81654EFF-703D-4AC5-AB14-337C1228702A Q26996078-04733D87-4CC7-4E0C-B99E-4C7D72B86FFC Q27687320-08F8CB32-DCAA-43B9-83A0-A0F5C7E4F059 Q27691453-9C525D50-040D-4EE8-9A32-BA73191956BD Q30251927-07A8A930-B27B-425F-834B-8EC91CABF864 Q33161066-A227615A-984C-48D5-B910-7190D169F90E Q33163446-DF006EFC-1D47-403F-87A7-3E13DC05A106 Q33166789-1AC2CE6B-D0C4-4F74-AD6B-7FB452142204 Q34479289-E5664261-5AD9-42B5-A5D2-0FBCB45B0E00 Q35053507-7F35E732-DD84-4DF5-B580-6FF1D3CF71F0 Q35086382-9695D34E-948A-46B4-9586-EA8D58E91E6B Q35869437-F5A15B1F-D56A-4DDA-A81F-43AC3B9C22EE Q36223055-42608F1B-08A0-4BA6-BC00-1D9D1355CCB3 Q36359027-E8B25CC0-DFF6-4776-A9ED-76A2D4BC7B30 Q36718346-BF9F8561-1EA9-46C8-946A-35604ABFB12C Q36977243-FF150FE2-218C-49A5-A12F-F8235D930E85 Q37133801-9D16787D-21B6-432B-BFE4-51AF56074ECF Q37248319-D577BD96-F907-46DC-AE37-5C15D5375978 Q37540604-CBB17F27-C05E-407B-8086-5255E5E53E46 Q37540613-2F225856-3D7A-4395-A5D5-706C09787C95 Q37581267-80AF80F8-109E-4092-9507-622C1EBA0A13 Q37879213-133A38F7-DA00-452F-ABAE-3133EF86563F Q38065713-9B7CCEA4-630F-4FAF-B40B-C2E2BADB4983 Q38175197-441825FD-72BF-4AB6-8022-87156BBEE730 Q38232339-6744B2A7-4CD4-448E-87FA-6EE467B8747C Q38271628-B79C2EBB-3F7C-4371-A51A-5D49D1E95F87 Q38341953-CDE5697F-3CFF-4542-BBD1-A5831F323D6D Q38349395-1DF9139D-578B-49D1-9B88-90C038DE6A3B Q38557105-25455BEA-429D-44D8-A4F7-3841618C6A93 Q38652768-8BF8811B-3DD6-4988-870C-B7627AA3CD6F Q38795717-E9D566C1-F3A6-489C-BFF7-9233A90CC116 Q39025680-F466BC50-F1B1-449A-AFC5-47C2A36845F8 Q39213902-BD14FCC1-9399-4A9D-950E-C179D2BBA1C6 Q39938292-6E6FBBEB-AB9E-43B1-B81D-0ED07011EC93 Q40275640-7D36DAAA-7C7A-449A-B3FE-4D1109591411 Q43680261-DC1483DB-2DC1-453F-94FF-EF37110330E3 Q47292273-AF2DFAA1-5252-4856-AAAD-3C2297709379 Q50672722-4E3CE110-B5AA-4316-A520-4889BD1D7A50 Q57603148-B6AA3EEE-D944-402E-ADDC-63573A30F647

P2860

Long-term outcomes in children with pulmonary arterial hypertension treated with bosentan in real-world clinical settings

http://www.wikidata.org/entity/Q34254924

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Long-term outcomes in children ...... n real-world clinical settings

@ast

Long-term outcomes in children ...... n real-world clinical settings

@en

Long-term outcomes in children ...... n real-world clinical settings

@nl

type

label

Long-term outcomes in children ...... n real-world clinical settings

@ast

Long-term outcomes in children ...... n real-world clinical settings

@en

Long-term outcomes in children ...... n real-world clinical settings

@nl

prefLabel

Long-term outcomes in children ...... n real-world clinical settings

@ast

Long-term outcomes in children ...... n real-world clinical settings

@en

Long-term outcomes in children ...... n real-world clinical settings

@nl

P1433

Q34254924-96034A0F-E4F4-47A4-A156-BC9E1CBD02F4

P1476

Q34254924-0EF1B21B-E772-44F2-8556-F05335E82518

P2093

Q34254924-04A2CA94-1E3B-4C64-9F86-4801B100ABCC

Q34254924-3674D587-AB26-4BF8-84A8-1F0904E8E5B2

Q34254924-4DB06B95-A380-4C51-9B14-865099DB0F20

Q34254924-A433D5B8-D8DD-4998-ACCA-42B199B03DC0

Q34254924-EAEBDB99-CF67-4A5D-BA5D-6A8DCD347996

Q34254924-F6D223A2-6C6F-442F-8662-EFA1FCFE6EF6

P2860

Q34254924-073F13E2-A54F-4C64-98B2-5667582957FE

Q34254924-0D5E39DD-A57E-4EF5-8A12-0390E7AEE4FD

Q34254924-1BDBB60C-7A9B-4028-BA52-C3A05B9A504A

Q34254924-51470BEA-9850-427F-9929-894DFA562B53

Q34254924-661E8704-257D-4CD9-B636-080640692A16

Q34254924-6DFBC90C-8184-46FE-8AB4-BDB066F86339

Q34254924-75A7096E-B8AB-40B3-8B87-8482E9019906

Q34254924-9801124B-2996-49BB-9090-979ACDC8AEFB

Q34254924-9F76EA18-03B9-4613-A9CE-6EDFBA2ED120

Q34254924-A358AE3E-CDCC-469B-8C8A-67D91F69FF0A

P304

Q34254924-3DA05659-75BE-467B-A0A2-BDD7778BF0CC

P31

Q34254924-9E70090B-4A56-4B82-94FE-2EF23A0529AD

P356

Q34254924-395E9017-7B57-4694-93C9-B7CAF3A07435

P407

Q34254924-41AD8192-CEBB-4587-A14E-BE7047A0CC09

P433

Q34254924-78C276F2-16E6-4899-82CF-0B9A00963809

P478

Q34254924-59420215-4250-4339-A188-AEFBE29FC833

P577

Q34254924-B941A664-F25C-47A0-88A5-D0EC521B99D3

P5875

Q34254924-7383C1BA-43A7-4175-880E-2C0C1F6C77FD

P698

Q34254924-4A9F27A7-36B6-4B13-BB1B-A35D37E93E5B

P932

Q34254924-DAF657BB-9E97-456A-A32B-A57B9A71C074

P356

J.AMJCARD.2010.06.064

P1433

American Journal of Cardiology

P1476

Long-term outcomes in children ...... n real-world clinical settings

@en

P2093

D Dunbar Ivy

http://www.w3.org/2001/XMLSchema#string

Daniel Rosenberg

http://www.w3.org/2001/XMLSchema#string

Erika Berman Rosenzweig

http://www.w3.org/2001/XMLSchema#string

Jean-Christophe Lemarié

http://www.w3.org/2001/XMLSchema#string

Monika Brand

http://www.w3.org/2001/XMLSchema#string

Robyn J Barst

http://www.w3.org/2001/XMLSchema#string

P2860

Survival with first-line bosentan in patients with primary pulmonary hypertension.

Pulmonary arterial hypertension in children.

Weaning and discontinuation of epoprostenol in children with idiopathic pulmonary arterial hypertension receiving concomitant bosentan.

Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol

Recommendations on the management of pulmonary hypertension in clinical practice.

Response to bosentan in children with pulmonary hypertension.

Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension.

Idiopathic pulmonary arterial hypertension in children.

Suggestions for STROBE recommendations.

Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study.

P304

1332-1338

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.AMJCARD.2010.06.064

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47620848

http://www.w3.org/2001/XMLSchema#string

P698

21029834

http://www.w3.org/2001/XMLSchema#string

P932

2966874

http://www.w3.org/2001/XMLSchema#string